期刊文献+

环氧化酶-2在胃癌组织中的表达及其与血管生成的关系 被引量:18

Relationship between cyclooxygenase-2 expression and angiogenesis in patients with gastric cancer
原文传递
导出
摘要 目的探讨环氧化酶-2(COX-2)在胃癌组织中的表达及其与肿瘤血管生成的关系。方法应用免疫组织化学(免疫组化)法检测96例胃癌手术切除标本中COX-2的表达,采用抗CD34抗体标记微血管内皮细胞,计算微血管密度(MVD)。分析COX-2表达与MVD和胃癌主要临床病理特征的相关性。结果胃癌组织COX-2阳性表达率和MVD分别为80.2%和32.5±8.3,显著高于正常胃黏膜的13.3%和13.1±2.4;P<0.01。临床TNM分期中Ⅲ、Ⅳ期胃癌标本COX-2表达率与MVD为91.4%和34.9±8.7,显著高于Ⅰ和Ⅱ期胃癌标本(P<0.01)。伴有淋巴结转移的胃癌组织中COX-2表达率和MVD分别为87.9%和35.0±8.5,与无淋巴结转移病例相比,差异有统计学意义(P<0.05)。Spearman等级相关分析表明,COX-2表达与MVD呈显著正相关(γ=0.311,P<0.01)。结论COX-2表达在胃癌的肿瘤血管生成中起重要作用,COX-2及其诱导的血管生成与胃癌的浸润和转移密切相关。 Objective To investigate COX- 2 expression in patients with gastric cancer and its relationship with angiogenesis and clinicopathologic features of gastric cancer. Methods COX- 2 expression and CD34- stained microvessel density (MVD) were detected by immunohistochemical methods in specimens from 96 patients with gastric cancer. The correlations among COX- 2 expression, MVD and clinicopathologic features were analyzed. Results The COX- 2 positive rate and MVD in gastric cancer were significantly higher than those in the normal gastric mucosa (80.2% vs. 13.3% ;32.5± 8.3 vs. 13.1± 2.4, all P< 0.01). The COX- 2 positive rate and MVD in the patients with stage Ⅲ and Ⅳ were significantly higher (91.4% and 34.9± 8.7 respectively,P< 0.01),than that in the patients with stage Ⅰ and Ⅱ . The COX- 2 positive rate and MVD in the cases with lymph node metastasis were 87.9% and (35.0± 8.5) respectively, higher than those in the cases without lymph node metastasis (P< 0.05). The Spearman rank correlation test showed a significant correlation between COX- 2 expression and tumor MVD (r=0.311, P< 0.01). Conclusions COX- 2 plays an important role in gastric cancer angiogenesis. COX- 2 and angiogenesis induced by COX- 2 contribute to tumor invasion and lymph node metastasis.
出处 《中华胃肠外科杂志》 CAS 2005年第4期343-347,共5页 Chinese Journal of Gastrointestinal Surgery
基金 教育部留学回国人员科研启动基金(编号:9247342057) 江苏省卫生厅"135工程"医学重点人才基金(苏卫科教[2003]19号)
  • 相关文献

参考文献18

  • 1Folkman J.Tumor angiogenesis:therapeutic implications.N Engl J Med,1971,285:1182-1186.
  • 2Che X,Hokita S,Natsugoe S,et al.Tumor angiogenesis related to growth pattern and lymph node metastasis in early gastric cancer.Chin Med J (Engl),1998,111:1090-1093.
  • 3Shimoyama S,Kaminishi M.Increased angiogenin expression in gastric cancer correlated with cancer progression.J Cancer Res Clin Oncol,2000,126:468-474.
  • 4Yoshikawa T,Yanoma S,Tsuburaya A,et al.Angiogenesis inhibitor,TNP-470,suppresses growth of peritoneal disseminating foci.Hepatogastroenterology,2000,47:298-302.
  • 5Weidner N,Folkman J,Pozza F,et al.Tumor angiogenesis:a new significant and independent prognostic indicator in early-stage breast carcinoma.J Natl Cancer Inst,1992,84:1875-1887.
  • 6孙为豪,俞谦,曹大中,欧希龙,俞婷,钱铖,朱峰,孙运良.幽门螺杆菌感染和环氧合酶-2表达在胃癌发生中的作用[J].肿瘤,2004,24(1):38-41. 被引量:15
  • 7Uefuji K,Ichikura T,Mochizuki H.Expression of cyclooxygenase-2 in human gastric adenomas and adenocarcinomas.J Surg Oncol,2001,76:26-30.
  • 8Fosslien E.Molecular pathology of cyclooxygenase-2 in neoplasia.Ann Clin Lab Sci,2000,30:3-21.
  • 9O' Mahony CA,Beauchamp RD,Albo D,et al.Cyclooxygenase-2 alters transforming growth factor-beta 1 response during intestinal tumorigenesis.Surgery,1999,126:364-370.
  • 10Tsujii M,DuBois RN.Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.Cell,1995,83:493-501.

二级参考文献17

  • 1Correa P. Helicobacter pylori and gastric carcinogenesis[J]. Am J Surg Pathol, 1995, 19(suppl 1) : S37.
  • 2Kawabe A, Shimada Y, Uchida S, et al. Expression of cyclooxygenase-2 in primary and remnant gastric carcinoma: comparing it with p53 accumulation, Helicobacter pylori infection, and vascular endothelial growth factor expression [J]. J Surg Oncol, 2002, 80(2) : 79.
  • 3van Rees BP, Saukkonen K, Ristimaki A, et al. Cyclooxygenase-2 expression during carcinogenesis in the human stomach [J]. J Pathol, 2002, 196(2): 171.
  • 4Uefuji K, Ichikura T, Mochizuki H. Expression of cyclooxygenase-2 in human gastric adenomas and adenocarcinomas[J]. J Surg Oncol, 2001, 76(1): 26.
  • 5Wilson KT, Fu S, Ramanujam KS, et al. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinoma[J]. Cancer Res, 1998, 58(14): 2929.
  • 6McCarthy CJ, Crofford LJ, Greenson J, et al. Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection[J]. Am J Gastroenterol, 1999, 94(5): 1218.
  • 7Yu J, Leung WK, Ebert MP, et al. Increased expression of survivin in gastric cancer patients and in first degree relatives[J]. Br J Cancer, 2002, 87(1) : 91.
  • 8Yamagata R, Shimoyama T, Fukuda S, et al. Cyclooxygenase-2 expression is increased in early intestinal-type gastric cancer and gastric mucosa with intestinal metaplasia[J]. Eur J Gastroenterol Hepatol, 2002, 14(4) : 359.
  • 9Fukutake M, Nakatsugi S, Isoi T, et al. Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice[J]. Carcinogenesis, 1998, 19(11) : 1939.
  • 10Lim HY, Joo HJ, Choi JH, et al. Increased expression of cyclooxygenase-2 protein in human gastric carcinoma[J]. Clin Cancer Res, 2000, 6(2): 519.

共引文献14

同被引文献138

引证文献18

二级引证文献97

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部